Christian E. Gruber, Ph.D.
President and Chief Executive Officer

Chris Gruber has over 20 years experience in biotechnology. He is a co-founder of Express Genomics, Inc. and has served as the Company’s President and Chief Executive Officer since its inception in 2002. Dr. Gruber has authored many scientific publications in the field of molecular biology, in particular, cDNA synthesis and cloning. Prior to founding Express Genomics, Inc., he led product development efforts in the cDNA library technology and cDNA library services groups at Life Technologies (now Invitrogen). Dr. Gruber holds a doctorate degree in Microbiology and Immunology from the Wayne State University School of Medicine and a Bachelor of Science degree from the University of Michigan.

Mark Smith, Ph.D.
Vice President and Chief Scientific Officer

Mark Smith has 8 years experience in biotechnology production and services and 20 years experience in academic research. He is co-founder of Express Genomics, Inc. and has served as the company’s Vice President and Chief Scientific Officer since its inception in 2002. Dr. Smith has authored over 50 peer-reviewed manuscripts in the field of Molecular Oncology, having investigated and mapped the Ras-mediated signal transduction pathway that has been found to be associated with the development and progression of many human cancers. Prior to founding Express Genomics he worked at Life Technologies, Inc. developing novel cDNA synthesis and cloning technology platforms and was a principal investigator at the Frederick Cancer Research Center, an extension of the National Cancer Institute. Dr. Smith holds a doctorate degree in Biochemistry and Virology from Brigham Young University in Utah, and performed post-doctoral research at the Roche Institute of Molecular biology in New Jersey.